(Press-News.org) Philadelphia, January 29, 2021--Researchers at Children's Hospital of Philadelphia (CHOP) have developed a gene therapy vector for blood disorders like sickle cell disease and beta-thalassemia that is potentially safer and more effective than those currently used in gene therapy trials for those conditions. The vector, an engineered vehicle for delivering functional copies of the hemoglobin gene to correct a genetic abnormality, leads to the production of more hemoglobin with a lower dose, minimizing the risk of toxic side effects.
The findings were published today in Molecular Therapy.
"These results have many potential benefits for the successful treatment of patients affected by beta-globinopathies like sickle cell disease and beta-thalassemia, including a better dose response, a minimized chance of clonal expansion and tumorigenesis, a reduced cost of therapy, and a potentially reduced need for chemotherapy or radiation before beginning gene therapy," said Laura Breda, PhD, research assistant professor at CHOP and first author of the paper. "All of us in the CuRED Frontier Program at CHOP are dedicated to finding new and improved curative therapies for blood disorders, and we look forward to taking steps to move this vector into clinical trials."
Sickle cell disease and beta-thalassemia are genetic blood disorders caused by errors in the genes for hemoglobin, a protein consisting of globin and iron-containing subunits that is found in red blood cells and carries oxygen from the lungs to tissues throughout the body. The disorders, sometimes referred to as beta-globinopathies due to mutations in the beta-globin gene, lead to serious health complications, ranging from delayed growth and jaundice to pain crises, pulmonary hypertension, and stroke.
Because children with beta-globinopathies have two abnormal copies of the hemoglobin gene - one from each parent - researchers have explored gene therapy as a potential breakthrough treatment. Using an engineered carrier called a vector to introduce a functional copy of the beta-globin gene, this therapy has the potential to restore normal hemoglobin production in patients with beta-globinopathies. However, there are challenges to this approach, including limited dose response, dose-related toxicities, and the need in many cases for myeloablation, a procedure in which the bone marrow is suppressed via chemotherapy or radiation before gene therapy can begin.
In order to reduce unwanted side effects and increase effectiveness of gene therapy for these conditions, the CHOP researchers developed a new vector using an engineered lentivirus, the same retrovirus used to create gene therapy vectors in ongoing gene therapy trials for beta-globinopathies. The lentiviral vectors currently in use all contain the human beta-globin gene along with its promoter; three so-called hypersensitive sites that are important for gene transcription; and a truncated version of intron 2, which does not code for proteins.
The CHOP researchers hypothesized that including the full intron, rather than a truncated one, in addition to other genomic elements that promote uniform expression of the beta-globin gene would enhance beta-globin - and thus functional hemoglobin - expression. Based on this hypothesis, the research team generated five novel lentiviral vectors by combining different additional genomic elements. As a benchmark, they also generated three vectors similar to those that have already been used in clinical trials, which they used to compare to their novel vectors.
Using a variety of in vitro and in vivo screening approaches, the researchers found that one of their vectors, ALS20, expressed significantly higher transgenic hemoglobin levels than other vectors currently used to treat beta-globinopathies. Compared with the three benchmark vectors, ALS20 produced 157%, 84%, and 40% more adult hemoglobin, which would have a greater clinical impact on patients, especially those who require higher hemoglobin production to become transfusion independent. ALS20 was also more powerful, with a lower dose providing higher hemoglobin production, which could reduce the need for myeloablation and possibly allow for in vivo delivery methods.
From a safety standpoint, ALS20 viral particles did not contain unwanted genomic RNA byproducts, and mice treated with ALS20 exhibited normal physiology without any proliferative disorders or cancerous formations compared with controls.
"Considering the body of evidence presented in this work, we believe that ALS20 is an outstanding candidate for the successful treatment of beta-globinopathies," said senior author Stefano Rivella, PhD, Kwame Ohene-Frempong Chair on Sickle Cell Anemia and Professor of Pediatrics at CHOP. "Our vector may not only provide safer therapy with a reduced probability of genome toxicity and milder conditioning requirements, but it may also improve the efficacy and offer a competitive product for the gene therapy market."
INFORMATION:
The research was supported by the Comprehensive Center for the Cure of Sickle Cell Disease and other Red Cell Disorders (CuRED) - Frontier Program at CHOP, the Commonwealth Universal Research Enhancement Program (CURE) - Department of Health of Pennsylvania, and the Associazione Veneta per la Lotta alla Talassemia (AVLT). The team also received support through private donations, including those from the 2018 CHOP Daisy Days campaign and The Runway.
Breda L, Ghiaccio V, Tanaka N, Jarocha D, Ikawa Y, Abdulmalik O, Dong A, Casu C, Raabe TD, Shan X, Danet-Desnoyers GA, Doto AM, Everett J, Bushman FD, Radaelli E, Assenmacher CA, Tarrant JC, Hoepp N, Guzikowski V, Smith-Whitley K, Kwiatkowski JL, and Rivella S. "Lentiviral vector ALS20 yields high hemoglobin levels with low genomic integrations for treatment of beta-globinopathies," Molecular Therapy, online January 29, 2021. DOI: 10.1016/j.ymthe.2020.12.036
About Children's Hospital of Philadelphia: Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals, and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country. In addition, its unique family-centered care and public service programs have brought the 595-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu
PITTSBURGH, Jan. 29, 2021 - A study led by UPMC Children's Hospital of Pittsburgh and the University of Pittsburgh School of Medicine shows that Black children are 18% less likely to get imaging tests as part of their emergency department visit compared to White children. Hispanic children are 13% less likely to have imaging done than Whites.
The researchers suggest that this disparity results from overuse in White children, though underuse in minority children probably plays a part as well. The root cause likely stems from both patient preferences and implicit bias among providers.
"Something else is going on here that's beyond the clinical, that's beyond the diagnoses," said study lead author Jennifer Marin, M.D., M.Sc., associate ...
In just one year, COVID-19 has killed more than 400,000 Americans, and infected more than 24 million others. But a new study shows just how unevenly those deaths and cases have played out across the country.
It finds that the more disadvantaged a county's population was before the pandemic, the higher the toll of coronavirus last spring and summer.
That level of disadvantage, measured on a standard scale called the Social Vulnerability Index (SVI), tracked closely with the number of cases and deaths per 100,000 residents in each county, according to the new University of Michigan study.
The ten-point SVI score combines many measures of the social disadvantage of a county's population, with higher scores meaning greater disadvantage. For every ...
What The Study Did: Maternally derived antibodies are a key element of neonatal immunity. This study examined the association between maternal and neonatal SARS-CoV-2-specific antibody concentrations because understanding the dynamics of maternal antibody responses to SARS-CoV-2 infection during pregnancy and subsequent transplacental antibody transfer can inform neonatal management as well as maternal vaccination strategies.
Authors: Scott E. Hensley, Ph.D., of the University of Pennsylvania in Philadelphia, and Karen M. Puopolo, M.D., Ph.D., of the Children's Hospital of Philadelphia, are the corresponding authors.
To ...
What The Study Did: Researchers investigated the association between county-level social risk factors and COVID-19 cases and deaths, as well as weekly changes in cumulative cases and mortality, using publicly available data sets as of July 29, 2020.
Authors: Renuka Tipirneni, M.D., M.Sc., of the University of Michigan in Ann Arbor, is th corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2020.36462)
Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article ...
What The Study Did: This study investigated how unemployment insurance and a $600 per week federal supplement to unemployment insurance were associated with food insecurity among people in low- and middle-income households who lost jobs during the COVID-19 pandemic.
Authors: Julia Raifman, Sc.D., of the Boston University School of Public Health, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2020.35884)
Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict ...
What The Study Did: Researchers examined if the use of diagnostic imaging for children receiving care in pediatric emergency departments in the United States differs by race and ethnicity.
Authors: Jennifer R. Marin, M.D., M.Sc., of the University of Pittsburgh School of Medicine, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2020.33710)
Editor's Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, ...
Researchers at the University of Arizona are developing a COVID-19 testing method that uses a smartphone microscope to analyze saliva samples and deliver results in about 10 minutes.
The UArizona research team, led by biomedical engineering professor Jeong-Yeol Yoon, aims to combine the speed of existing nasal swab antigen tests with the high accuracy of nasal swab PCR, or polymerase chain reaction, tests. The researchers are adapting an inexpensive method that they originally created to detect norovirus - the microbe famous for spreading on cruise ships - using a smartphone microscope.
They plan to use the method in conjunction with a saline swish-gargle test developed by Michael Worobey, ...
Evidence is emerging that vitamin D - and possibly vitamins K and A - might help combat COVID-19. A new study from the University of Bristol published in the journal of the German Chemical Society Angewandte Chemie has shown how they - and other antiviral drugs - might work. The research indicates that these dietary supplements and compounds could bind to the viral spike protein and so might reduce SARS-CoV-2 infectivity. In contrast, cholesterol may increase infectivity, which could explain why having high cholesterol is considered a risk factor for serious ...
An international team of researchers led by Oxford Brookes University shows that black howler monkeys in Mexico not only remember where important events took place in their habitat, but also when to return to such locations.
The researchers recorded the behaviour of five groups of black howler monkeys accumulating over 3,000 hours of field observations at Palenque National Park, southern Mexico.
Expert fruit foragers
Black howler monkeys were observed navigating deliberately towards out of sight fruit trees that were ripening. Fruit is a desired food by many animals in rainforests so being able to anticipate when fruit is going to be available and where, is a great strategy to forage ahead of competitors. ...
This is the conclusion of a recent study by an international team of researchers, including Anne-Marie Elbe, Professor of Sports Psychology at Leipzig University. The finding is of social importance because experiences in adolescence in particular have a formative influence on attitudes and behaviour in later life.
In sport, football is considered a model of inclusion. "Remarkably, to the best of our knowledge, theory and research on feelings of inclusion in (youth) team sports is lacking," the authors write in their study. They add that filling this gap is important, because team sports are not necessarily inclusive by nature.
For ...
